Financial Strain Linked to Greater Symptom Burden for Patients With Colorectal, Lung Cancer

Possible correlation between symptom burden for patients with lung or colorectal cancer and their financial issues.
Possible correlation between symptom burden for patients with lung or colorectal cancer and their financial issues.

A recent study examined the possible correlation between symptom burden for patients with lung or colorectal cancer and their financial issues.1

Researchers affiliated with the Dana-Farber Cancer Institute, Boston; Duke University School of Medicine; University of Michigan; and Harvard T.H. Chan School of Public Health interviewed patients with colorectal or lung cancer diagnoses about their financial strain, quality of life, and symptom severity. Interviews were conducted at 4 and (when possible) 12 months after diagnosis.

The EuroQoL-5 Dimension Scale and the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 were utilized to determine quality of life, and in turn associated with financial situation via linear regression models that incorporated demographic factors, cancer stage at diagnosis, and any comorbidities.

Patients with lung or colorectal cancer reported greater symptom burden, worse quality of life, and higher degrees of reported pain when limited financial reserves were a factor.

Forty percent of patients with lung cancer and 33% of patients with colorectal cancer reported a degree of financial strain (fiscal reserves equal to or less than 2 months).

The link between financial strain and these medical issues continued for survivors at the 1-year mark and beyond, even after adjustment for cancer stage and comorbidity. The research team concluded that additional support to those patients identified as having low financial reserves would prove beneficial.

REFERENCE

1. Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D. Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer [published online ahead of print February 29, 2016]. J Clin Oncol. doi:10.1200/JCO.2015.63.2232.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs